This content is from: European Union

Why PhRMA wants the EU on the USTR’s IP watch list

Pharmaceutical industry organisation PhRMA has asked the US government to put the EU on the USTR’s Special 301 Report, which identifies countries the US views as the worst offenders when it comes to IP, in a move that has left PhRMA's critics extremely concerned

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial